Carregant...
Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
OBJECTIVE: To examine the impact of withdrawing rosiglitazone and ramipril medication on diabetes incidence after closeout of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. RESEARCH DESIGN AND METHODS: The 3,366 DREAM subjects at trial end who had not dev...
Guardat en:
| Format: | Artigo |
|---|---|
| Idioma: | Inglês |
| Publicat: |
American Diabetes Association
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3114353/ https://ncbi.nlm.nih.gov/pubmed/21515846 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc10-1567 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|